These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5047938)

  • 21. Strain differences during intraventricular infusion of norepinephrine: possible role of receptor sensitivity.
    Segal DS; Geyer MA; Weiner BE
    Science; 1975 Jul; 189(4199):301-3. PubMed ID: 1145205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the effects of fenfluramine and amphetamine on uptake release and catabolism of norepinephrine in rat brain.
    Ziance RJ; Rutledge CO
    J Pharmacol Exp Ther; 1972 Jan; 180(1):118-26. PubMed ID: 5010409
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative effects of P-chloroamphetamine and amphetamine on metabolism and in vivo release of 3 H-norepinephrine in the hypothalamus.
    Strada SJ; Sulser F
    Eur J Pharmacol; 1971 Jun; 15(1):45-51. PubMed ID: 5161340
    [No Abstract]   [Full Text] [Related]  

  • 24. Naloxone potentiates the disruptive effects of mescaline on operant responding in the rat.
    Commissaris RL; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1980 Oct; 13(4):601-3. PubMed ID: 7433492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Micro-injection of 3H-acetylcholine, 14C-serotonin and 3H-norepinephrine into the hypothalamus of the rat: diffusion into tissue and ventricles.
    Myers RD; Tytell M; Kawa A; Rudy T
    Physiol Behav; 1971 Nov; 7(5):743-51. PubMed ID: 4950648
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative effects of dl-p-methoxyamphetamine and d-amphetamine on catecholamine release and reuptake in vitro.
    Tseng LF; Hitzemann RJ; Loh HH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):708-16. PubMed ID: 4843169
    [No Abstract]   [Full Text] [Related]  

  • 27. Environmental influences upon drug-induced suppression of operant behavior.
    Sparber SB; Tilson HA
    J Pharmacol Exp Ther; 1971 Oct; 179(1):1-9. PubMed ID: 5096565
    [No Abstract]   [Full Text] [Related]  

  • 28. The delay of the behavioral effects of 9 -tetrahydrocannabinol in rats by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A).
    Peterson DW; Cohen GM; Sparber SB
    Life Sci I; 1971 Dec; 10(24):1381-6. PubMed ID: 5146321
    [No Abstract]   [Full Text] [Related]  

  • 29. Norepinephrine diffusion from hypothalamus to cerebrospinal fluid and cerebrospinal fluid to hypothalamus of sheep.
    Forbes JM; Baile CA
    J Dairy Sci; 1974 Jul; 57(7):826-32. PubMed ID: 4407515
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of nicotine on the release of 3 H-noradrenaline from the hypothalamus.
    Hall GH; Turner DM
    Biochem Pharmacol; 1972 Jul; 21(13):1829-38. PubMed ID: 4646185
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of 6-hydroxydopamine and reserpine on amphetamine-induced release of norepinephrine in rat cerebral cortex.
    Kalisker A; Waymire JC; Rutledge CO
    J Pharmacol Exp Ther; 1975 Apr; 193(1):64-72. PubMed ID: 237115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine.
    Arnold EB; Molinoff PB; Rutledge CO
    J Pharmacol Exp Ther; 1977 Sep; 202(3):544-57. PubMed ID: 894521
    [No Abstract]   [Full Text] [Related]  

  • 33. Serotonin and behavioral inhibition.
    Stein L; Wise CD
    Adv Biochem Psychopharmacol; 1974; 11(0):281-91. PubMed ID: 4276861
    [No Abstract]   [Full Text] [Related]  

  • 34. Collection of (3H) norepinephrine in ventriculo-cisternal perfusate during hypothalamic stimulation in cat.
    Sweet RD; Reis DJ
    Brain Res; 1971 Oct; 33(2):584-8. PubMed ID: 5134945
    [No Abstract]   [Full Text] [Related]  

  • 35. Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride.
    Mokler DJ; Rech RH
    Pharmacol Biochem Behav; 1984 Aug; 21(2):281-7. PubMed ID: 6483939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of learning, amphetamine and nicotine on the level and synthesis of brain noradrenaline in rats.
    Fulginiti S; Orsingher OA
    Arch Int Pharmacodyn Ther; 1971 Apr; 190(2):291-8. PubMed ID: 5575583
    [No Abstract]   [Full Text] [Related]  

  • 37. Proceedings: Diffusion of noradrenaline between hypothalamus and cerebral ventricles of sheep.
    Baile CA; Forbes JM
    J Physiol; 1973 Oct; 234(2):44P-46P. PubMed ID: 4767061
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of phenylethanolamine N-methyltransferase inhibitors on uptake and release of norepinephrine and dopamine from rat brain.
    Liang NY; Hower JA; Borchardt RT
    Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):467-70. PubMed ID: 4059661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms by which amphetamine and desipramine inhibit the metaraminol-induced release of norepinephrine from sympathetic nerve endings in rat heart.
    Leitz FH
    J Pharmacol Exp Ther; 1970 May; 173(1):152-7. PubMed ID: 5442296
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential sensitivity of amygdala and hypothalamus to amphetamine-induced release of norepinephrine.
    Ebstein RP; Ebstein BS; Samuel D; Berger BD
    J Neurochem; 1972 Nov; 19(11):2703-5. PubMed ID: 5086253
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.